Clene Inc. Warrant

$0.862
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0521 (-5.70%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can watch CLNNW and buy or sell other stocks, options, and ETFs commission-free!

About CLNNW

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.

CEO
Robert Dee Etherington, MBA
Employees
—
Headquarters
Salt Lake City, Utah
Founded
2013
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.70K
High Today
$0.9001
Low Today
$0.8001
Open Price
$0.8701
Volume
24.57K
52 Week High
$2.40
52 Week Low
$0.035

You May Also Like

FXL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure